World's Best Scientists 2026 revealed!
Mårten Segelmark

Mårten Segelmark

D-Index & Metrics

Microbiology

D-Index
56
Citations
15579
World Ranking
3664
National Ranking
72

Mårten Segelmark publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mårten Segelmark sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 185 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mårten Segelmark D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mårten Segelmark sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 56 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mårten Segelmark is affiliated with Lund University in Sweden and has a significant body of research primarily focused on medicine, with a strong emphasis on nephrology, pulmonary and respiratory medicine, and rheumatology. Their work intersects several subfields, including physiology and genetics.

The scientist has contributed extensively to topics related to vasculitis and associated conditions, renal diseases and glomerulopathies, as well as dialysis and renal disease management. Additional areas of study include chronic kidney disease and diabetes, coagulation processes, bradykinin, polyphosphates, and angioedema, along with sarcoidosis, beryllium toxicity research, and otitis media and relapsing polychondritis.

Notable recent publications by Mårten Segelmark include:

  • EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update, 2023, Annals of the Rheumatic Diseases
  • CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden, 2021, American Journal of Kidney Diseases
  • 2020 international consensus on ANCA testing beyond systemic vasculitis, 2020, Autoimmunity Reviews
  • Rituximab in Membranous Nephropathy, 2021, Kidney International Reports
  • Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?, 2020, Autoimmunity Reviews

The scientist frequently publishes in the following venues:

  • Nephrology Dialysis Transplantation
  • Lara D. Veeken
  • Kidney International Reports
  • Journal of the American Society of Nephrology
  • Clinical Kidney Journal

Mårten Segelmark has collaborated with several researchers with notable frequency, including:

  • Aladdin J Mohammad
  • Annette Bruchfeld
  • Andreas Kronbichler
  • David Jayne
  • Marie Evans

Best Publications

  • Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

    Rachel B. Jones;Jan Willem Cohen Tervaert;Thomas Hauser;Raashid Luqmani

  • Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

    Richard Watts;Suzanne Lane;Thomas Hanslik;Thomas Hauser

  • EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

    M. Yates;M. Yates;R. A. Watts;I. M. Bajema;M. C. Cid

  • Genetically Distinct Subsets within ANCA-Associated Vasculitis

    Paul A Lyons;Tim F Rayner;Sapna Trivedi;Julia U Holle

  • Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

    David R W Jayne;Annette N Bruchfeld;Lorraine Harper;Matthias Schaier

  • Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa

    Aladdin J Mohammad;Lennart T H Jacobsson;Kerstin W A Westman;Gunnar Sturfelt

  • Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

    Josef Coresh;Hiddo J L Heerspink;Yingying Sang;Kunihiro Matsushita

  • Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg–Strauss syndrome within a defined population in southern Sweden

    Aladdin Mohammad;L. T. H. Jacobsson;A. D. Mahr;Gunnar Sturfelt

  • Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

    Rachel B. Jones;Shunsuke Furuta;Jan Willem Cohen Tervaert;Thomas Hauser

  • Circulating microRNA expression profiles associated with systemic lupus erythematosus

    Anting Liu Carlsen;Aaron J Schetter;Christoffer Nielsen;Christian Lood

  • Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

    Stephen P. McAdoo;Anisha Tanna;Zdenka Hrušková;Lisa Holm

  • Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.

    Alexandre Karras;Christian Pagnoux;Marion Haubitz;Kirsten de Groot

  • EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

    Neil Basu;Richard Watts;Ingeborg Bajema;Bo Baslund

  • Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.

    Daniel Söderberg;Mårten Segelmark

  • CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden

    Oskar Swartling;Helena Rydell;Maria Stendahl;Mårten Segelmark

  • The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis

    Mårten Segelmark;Abdul Nasser Elzouki;Jörgen Wieslander;Sten Eriksson

  • Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis.

    Patrick H. Nachman;Mårten Segelmark;Kerstin Westman;Susan L. Hogan

  • Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?

    Mårten Segelmark;B Persson;Thomas Hellmark;Jörgen Wieslander

  • Diagnosis and classification of Goodpasture's disease (anti-GBM).

    Thomas Hellmark;Mårten Segelmark

  • Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants

    Jia Jin Yang;Gloria A. Preston;William F. Pendergraft;Mårten Segelmark

  • Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals

    Zhao Cui;Ming-hui Zhao;Mårten Segelmark;Thomas Hellmark

  • Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils

    Susanne Bauer;Mohamed Abdgawad;Lena Gunnarsson;Mårten Segelmark

Frequent Co-Authors

David Jayne
David Jayne University of Cambridge
Jörgen Wieslander
Jörgen Wieslander Lund University
Per Eriksson
Per Eriksson Karolinska University Hospital
Alan D. Salama
Alan D. Salama University College London
Richard A. Watts
Richard A. Watts University of East Anglia
Charles D. Pusey
Charles D. Pusey Imperial College London
Raashid Luqmani
Raashid Luqmani University of Oxford
Caroline O. S. Savage
Caroline O. S. Savage Academy of Medical Sciences
Jan Willem Cohen Tervaert
Jan Willem Cohen Tervaert University of Alberta
Diana Karpman
Diana Karpman Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths beyond the laboratory. For those interested in the intersection of health and patient care, becoming a functional medicine nurse practitioner is an emerging option. Exploring functional medicine np programs can provide the specialized training necessary for this role.

On the administrative side, careers in medical coding and health information are growing rapidly. Pursuing certification, such as a certified professional coder (cpc), can lead to stable and well-compensated positions within healthcare facilities.

For microbiology graduates interested in data management and healthcare systems, health information management offers substantive opportunities. Understanding health information management salary expectations helps gauge the career's financial benefits and growth potential.

To build a strong foundation, consider enrolling in one of the best online health information management degree cahiim accredited programs. These accredited degrees equip students with the credentials necessary to excel in the health information field.

Best Scientists Citing Mårten Segelmark

Trending Scientists

Recently Published Articles